Unspecified GLP-1
Sold by MyStart Health · every unspecified glp-1 record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$299
| Medication · Program, starts at (medication included) | $299 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Program, starts at (medication included) “The MyStart program starts at $299/month, excluding any discounts. This all-inclusive pricing covers physician evaluations, follow-up appointments, unlimited access to clinicians, monthly prescriptions, a 4-week or 12-week supply of medication (depending on your chosen plan), any necessary blood work, and shipping—guaranteed with no hidden fees.” | Per month$299 | Charged today$299 |
We earn nothing from this link. MyStart Health has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Prescriber | Asynchronous review |
|---|---|
| Cancellation | “Yes, you can cancel at any point. If you’d like to cancel, please send us an email at [email address] with "CANCEL" in the subject line, and our customer service agent will confirm your cancellation.” |
Not yet checked: pharmacy, states, membership and consult fee.
Recorded from mystarthealth.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — A testimonial on the homepage names "semaglutide" and the support FAQ page shows an article titled "How to inject compounded tirzepatide" describing a "vial/needle/syringe" method, confirming both drugs are offered as compounded injectables, but the $299/month price on the FAQ is a general program price not broken out per drug, so it is recorded as unspecified GLP-1 rather than assigned to one drug.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.